FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2779592308> ?p ?o ?g. }

• W2779592308 endingPage "731" @default.
• W2779592308 startingPage "723" @default.
• W2779592308 abstract "A subset of patients with non-small cell lung cancer (NSCLC) respond well to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), due to the presence of sensitising mutations in the gene encoding EGFR. Mutations associated with resistance to first generation EGFR TKIs have also been identified, which lead to therapeutic failure and the requirement for new drugs. Three generations of EGFR TKIs have been developed and either have been, or are being, evaluated as first and/or second line therapeutic agents. In this review, we consider the advances in molecular diagnostic techniques that are used, or are in development, to facilitate the targeted EGFR TKI therapy of patients with NSCLC. A literature search was conducted in May 2017 using PubMed, and spanning the period September 2005 (EU approval date of erlotinib) to May 2017. Search terms used were: EGFR TKI, NSCLC, clinical trial, erlotinib, gefitinib, afatinib, EGFR mutations, Exon 19 deletion, and Leu858Arg. The use of molecular data, in conjunction with other clinical and diagnostic information, will assist physicians to make the best therapeutic choice for each patient with advanced NSCLC. Personalized medicine and a rapidly developing therapy landscape will enable these patients to achieve optimal responses to EGFR TKIs." @default.
• W2779592308 created "2018-01-05" @default.
• W2779592308 creator A5010113291 @default.
• W2779592308 creator A5010620388 @default.
• W2779592308 creator A5037541807 @default.
• W2779592308 creator A5044994551 @default.
• W2779592308 creator A5063681577 @default.
• W2779592308 creator A5084754710 @default.
• W2779592308 date "2017-12-21" @default.
• W2779592308 modified "2023-09-29" @default.
• W2779592308 title "Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) – Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy" @default.
• W2779592308 cites W1546552389 @default.
• W2779592308 cites W1833874039 @default.
• W2779592308 cites W1940324115 @default.
• W2779592308 cites W1967394241 @default.
• W2779592308 cites W2005890747 @default.
• W2779592308 cites W2026951964 @default.
• W2779592308 cites W2043696829 @default.
• W2779592308 cites W2076466060 @default.
• W2779592308 cites W2076883919 @default.
• W2779592308 cites W2095618958 @default.
• W2779592308 cites W2096198395 @default.
• W2779592308 cites W2097560495 @default.
• W2779592308 cites W2101329867 @default.
• W2779592308 cites W2111662961 @default.
• W2779592308 cites W2122706875 @default.
• W2779592308 cites W2125195105 @default.
• W2779592308 cites W2125760261 @default.
• W2779592308 cites W2126491616 @default.
• W2779592308 cites W2129360604 @default.
• W2779592308 cites W2129590156 @default.
• W2779592308 cites W2132870547 @default.
• W2779592308 cites W2135192471 @default.
• W2779592308 cites W2139804581 @default.
• W2779592308 cites W2154149901 @default.
• W2779592308 cites W2158667695 @default.
• W2779592308 cites W2160982674 @default.
• W2779592308 cites W2161959587 @default.
• W2779592308 cites W2166084034 @default.
• W2779592308 cites W2168554121 @default.
• W2779592308 cites W2174033131 @default.
• W2779592308 cites W2180488232 @default.
• W2779592308 cites W2239287815 @default.
• W2779592308 cites W2273212719 @default.
• W2779592308 cites W2275877493 @default.
• W2779592308 cites W2301090715 @default.
• W2779592308 cites W2336745060 @default.
• W2779592308 cites W2337836619 @default.
• W2779592308 cites W2338078784 @default.
• W2779592308 cites W2339311613 @default.
• W2779592308 cites W2466657922 @default.
• W2779592308 cites W2469255185 @default.
• W2779592308 cites W2470636097 @default.
• W2779592308 cites W2527262883 @default.
• W2779592308 cites W2560717039 @default.
• W2779592308 cites W2561565091 @default.
• W2779592308 cites W2580557214 @default.
• W2779592308 cites W2581400993 @default.
• W2779592308 cites W2583905538 @default.
• W2779592308 cites W2587420003 @default.
• W2779592308 cites W2591118779 @default.
• W2779592308 cites W2594186252 @default.
• W2779592308 cites W2604698167 @default.
• W2779592308 cites W2627001967 @default.
• W2779592308 doi "https://doi.org/10.1007/s12253-017-0377-1" @default.
• W2779592308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29270776" @default.
• W2779592308 hasPublicationYear "2017" @default.
• W2779592308 type Work @default.
• W2779592308 sameAs 2779592308 @default.
• W2779592308 citedByCount "20" @default.
• W2779592308 countsByYear W27795923082018 @default.
• W2779592308 countsByYear W27795923082019 @default.
• W2779592308 countsByYear W27795923082020 @default.
• W2779592308 countsByYear W27795923082021 @default.
• W2779592308 countsByYear W27795923082022 @default.
• W2779592308 countsByYear W27795923082023 @default.
• W2779592308 crossrefType "journal-article" @default.
• W2779592308 hasAuthorship W2779592308A5010113291 @default.
• W2779592308 hasAuthorship W2779592308A5010620388 @default.
• W2779592308 hasAuthorship W2779592308A5037541807 @default.
• W2779592308 hasAuthorship W2779592308A5044994551 @default.
• W2779592308 hasAuthorship W2779592308A5063681577 @default.
• W2779592308 hasAuthorship W2779592308A5084754710 @default.
• W2779592308 hasConcept C121608353 @default.
• W2779592308 hasConcept C126322002 @default.
• W2779592308 hasConcept C143998085 @default.
• W2779592308 hasConcept C170493617 @default.
• W2779592308 hasConcept C2776256026 @default.
• W2779592308 hasConcept C2777506169 @default.
• W2779592308 hasConcept C2778087573 @default.
• W2779592308 hasConcept C2779438470 @default.
• W2779592308 hasConcept C2780580887 @default.
• W2779592308 hasConcept C2780586478 @default.
• W2779592308 hasConcept C2781230642 @default.
• W2779592308 hasConcept C2909325608 @default.
• W2779592308 hasConcept C32220436 @default.
• W2779592308 hasConcept C42362537 @default.
• W2779592308 hasConcept C502942594 @default.

• next